- Bladder cancer
- Kidney cancer
- Paraganglioma
- Paraganglioma pheochromocytoma
- Penile cancer
- Prostate cancer
- Testicular cancer
Lin Mei, MD
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Penn Medicine Provider
About me
- Assistant Professor of Clinical Medicine (Hematology-Oncology)
Spoken languages
English
English
Reviews
356 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Hematology, 2019
- Medical Oncology, 2019
- Internal Medicine, 2016
- American Heart Association, National
- American Society of Clinical Oncology, National
- American Society of Hematology, National
- Penn Genitourinary and Urologic Cancer Program
Treatments and conditions
Research
Publications
Flaig TW, Spiess PE, Abern M, An Y, Bangs R, Begovic J, Brown J, Buyyounouski MK, Chan K, Chang P, Chin AI, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kundu S, Lele SM, Luckenbaugh A, Maldonado J, Mei L, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Seyedin S, Siefker-Radtke AO, Stewart T, Sundi D, Swami U, Tollefson M, Wright JL, Cassara CJ, Sliker B. Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology , J Natl Compr Canc Netw: 2026
Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Narayan V, Mei L, Takvorian S, Haas NB, Parikh RB, Mistry R, Mamtani R. OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care , Oncologist: 2026
Nair RP, Du W, Mei L, Koga S. Artificial intelligence for detection, grading, and prognostication in prostate cancer pathology: A scoping review , Histol Histopathol: 2026
Mo G, Maier S, Doyle M, Sweeney S, Orellana J, Farago L, Lloyd A, Mawema H, Bajaj A, Mei L, Takvorian SU, Haas NB, Ky B, Leong D, Narayan V. Cardiovascular risk evaluation in men with prostate cancer study (CARE-PC): Pilot study to assess patient awareness and risk mitigation. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA.: 2026
Litt HK, Wodzinski A, Subramanian P, Donovan M, Vapiwala N, Parikh RB, Narayan V, Mei L, Takvorian SU, Balzer Haas N, Mistry R, and Mamtani R. OncoEducate: A pilot study of generative AI to support patient education in GU cancer care. , 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,713
Subramanian P, Barsouk A, Elghawy O, Sussman JH, Yaskolko M, Yang A, Xu J, and Mei L. EGFR, HER2 alterations in advanced urothelial carcinoma (aUC): A retrospective analysis on survival outcomes. , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Fran, CA., 44(7): 2026,787
Barsouk AA, Yang A, Sussman JH, Elghawy O, Xu J, Xu J, Meng L, Koga S, Du W, Mamtani R, Mei L. Survival Disparities by Sex, Race, and Age in the Era of Contemporary Advanced Urothelial Carcinoma Therapy: A Real-World Analysis , Clin Genitourin Cancer, 23(5): 2025,102395
Koga S, Mei L. Perioperative Durvalumab in Bladder Cancer , American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco, CA.: 2025
Koga S, Mei L. Perioperative Durvalumab in Bladder Cancer , N Engl J Med, 392(6): 2025,618-619
Adam Barsouk, Omar Elghawy, Austin Yang, Jonathan H. Sussman, Ronac Mamtani and Lin Mei Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment , Cancers, 16(19): 2024,3338